Selected research
Industry Research
Teglutik Industry Research Report 2026
Market perspective
The global Teglutik market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Teglutik is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Teglutik is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Teglutik is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Teglutik include Sun Pharma, Sanofi, Mylan Pharma, Lunan Pharma, Italfarmaco, Glemark Generics, Covis Pharma and Apotex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Teglutik market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Teglutik Market by Company
Sun Pharma
Sanofi
Mylan Pharma
Lunan Pharma
Italfarmaco
Glemark Generics
Covis Pharma
Apotex
Teglutik Segment by Type
With Film-coated
Without Film-coated
Teglutik Segment by Application
Hospital
Pharmacy
Teglutik Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Teglutik market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Teglutik and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Teglutik.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Teglutik manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Teglutik by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Teglutik in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- With Film-coated
- Without Film-coated
Applications
- Hospital
- Pharmacy
Companies covered
- Sun Pharma
- Sanofi
- Mylan Pharma
- Lunan Pharma
- Italfarmaco
- Glemark Generics
- Covis Pharma
- Apotex
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Teglutik Market Size (2021-2032)
- 2.2.2 Global Teglutik Sales (2021-2032)
- 2.2.3 Global Teglutik Market Average Price (2021-2032)
- 2.3 Teglutik by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 With Film-coated
- 2.3.3 Without Film-coated
- 2.4 Teglutik by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Teglutik Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Teglutik Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Teglutik Revenue of Manufacturers (2021-2026)
- 3.4 Global Teglutik Average Price by Manufacturers (2021-2026)
- 3.5 Global Teglutik Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Teglutik, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Teglutik, Product Type & Application
- 3.8 Global Manufacturers of Teglutik, Established Date
- 3.9 Global Teglutik Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sun Pharma
- 4.1.1 Sun Pharma Company Information
- 4.1.2 Sun Pharma Business Overview
- 4.1.3 Sun Pharma Teglutik Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sun Pharma Teglutik Product Portfolio
- 4.1.5 Sun Pharma Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Teglutik Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Teglutik Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Mylan Pharma
- 4.3.1 Mylan Pharma Company Information
- 4.3.2 Mylan Pharma Business Overview
- 4.3.3 Mylan Pharma Teglutik Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mylan Pharma Teglutik Product Portfolio
- 4.3.5 Mylan Pharma Recent Developments
- 4.4 Lunan Pharma
- 4.4.1 Lunan Pharma Company Information
- 4.4.2 Lunan Pharma Business Overview
- 4.4.3 Lunan Pharma Teglutik Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Lunan Pharma Teglutik Product Portfolio
- 4.4.5 Lunan Pharma Recent Developments
- 4.5 Italfarmaco
- 4.5.1 Italfarmaco Company Information
- 4.5.2 Italfarmaco Business Overview
- 4.5.3 Italfarmaco Teglutik Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Italfarmaco Teglutik Product Portfolio
- 4.5.5 Italfarmaco Recent Developments
- 4.6 Glemark Generics
- 4.6.1 Glemark Generics Company Information
- 4.6.2 Glemark Generics Business Overview
- 4.6.3 Glemark Generics Teglutik Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Glemark Generics Teglutik Product Portfolio
- 4.6.5 Glemark Generics Recent Developments
- 4.7 Covis Pharma
- 4.7.1 Covis Pharma Company Information
- 4.7.2 Covis Pharma Business Overview
- 4.7.3 Covis Pharma Teglutik Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Covis Pharma Teglutik Product Portfolio
- 4.7.5 Covis Pharma Recent Developments
- 4.8 Apotex
- 4.8.1 Apotex Company Information
- 4.8.2 Apotex Business Overview
- 4.8.3 Apotex Teglutik Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Apotex Teglutik Product Portfolio
- 4.8.5 Apotex Recent Developments
5 Global Teglutik Market Scenario by Region
- 5.1 Global Teglutik Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Teglutik Sales by Region: 2021-2032
- 5.2.1 Global Teglutik Sales by Region: 2021-2026
- 5.2.2 Global Teglutik Sales by Region: 2027-2032
- 5.3 Global Teglutik Revenue by Region: 2021-2032
- 5.3.1 Global Teglutik Revenue by Region: 2021-2026
- 5.3.2 Global Teglutik Revenue by Region: 2027-2032
- 5.4 North America Teglutik Market Facts & Figures by Country
- 5.4.1 North America Teglutik Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Teglutik Sales by Country (2021-2032)
- 5.4.3 North America Teglutik Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Teglutik Market Facts & Figures by Country
- 5.5.1 Europe Teglutik Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Teglutik Sales by Country (2021-2032)
- 5.5.3 Europe Teglutik Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Teglutik Market Facts & Figures by Country
- 5.6.1 Asia Pacific Teglutik Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Teglutik Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Teglutik Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Teglutik Market Facts & Figures by Country
- 5.7.1 South America Teglutik Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Teglutik Sales by Country (2021-2032)
- 5.7.3 South America Teglutik Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Teglutik Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Teglutik Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Teglutik Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Teglutik Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Teglutik Sales by Type (2021-2032)
- 6.1.1 Global Teglutik Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Teglutik Sales Market Share by Type (2021-2032)
- 6.2 Global Teglutik Revenue by Type (2021-2032)
- 6.2.1 Global Teglutik Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Teglutik Revenue Market Share by Type (2021-2032)
- 6.3 Global Teglutik Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Teglutik Sales by Application (2021-2032)
- 7.1.1 Global Teglutik Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Teglutik Sales Market Share by Application (2021-2032)
- 7.2 Global Teglutik Revenue by Application (2021-2032)
- 7.2.1 Global Teglutik Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Teglutik Revenue Market Share by Application (2021-2032)
- 7.3 Global Teglutik Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Teglutik Value Chain Analysis
- 8.1.1 Teglutik Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Teglutik Production Mode & Process
- 8.2 Teglutik Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Teglutik Distributors
- 8.2.3 Teglutik Customers
9 Global Teglutik Analyzing Market Dynamics
- 9.1 Teglutik Industry Trends
- 9.2 Teglutik Industry Drivers
- 9.3 Teglutik Industry Opportunities and Challenges
- 9.4 Teglutik Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst